HelpLegal StatementCorporate Site
LoginContactsSitemap
Roche IndexNews DatabaseDocument Center
  At Your Service   CompanyMediaHealthcareCareers






 
           
     
       
Year
2010
 2009

 
2010
Sr.No.
Date
News
       
24 June 06 Phase III study showed Avastin-based regimen helped women with advanced ovarian cancer live longer without their disease worsening Top
       
23 June 04 Roche presents early data on the next generation of therapeutic antibodies and other targeted therapies at ASCO Top
       
22 May 27 Roche’s Newly Launched Next-Generation DNA Sequencer Opens Innovation in Genomic Research to Broad Scientific Community Top
       
21 May 21 Roche to Present New Data on Different Approaches To Treating Cancer at ASCO Top
       
20 May 20 Phase III study showed first-line maintenance use of MabThera doubles likelihood of people with follicular lymphoma living without their disease worsening Top
       
19 May 19 Roche and Biogen Idec announce their decision to discontinue the ocrelizumab clinical development programme in patients with rheumatoid arthritis Top
       
18 Apr 28 Roche announces joint initiative to train healthcare workers in Africa's fight against cancer Top
       
17 Apr 15 Excellent growth in first quarter of 2010 Top
       
16 Apr 13 Roche acquires Medingo Ltd. and expands its position in the growing insulin delivery systems market Top
       
15 Mar 30 Xeloda in combination with oxaliplatin approved in Europe for the adjuvant treatment of patients with early colon cancer Top
       
14 Mar 25 Management Change Group Communications Top
       
13 Mar 18 Roche uniquely positioned to deliver long-term growth Top
       
12 Mar 12 Roche provides update on phase III study of Avastin in men with late stage prostate cancer Top
       
11 Mar 08 Roche and Biogen Idec decide to suspend Ocrelizumab treatment - Rheumatoid Arthritis development programme on hold Top
       
10 Mar 02 Roche Annual General Meeting: dividend raised by 20% Top
       
09 Feb 25 Avastin phase III study shows positive results in women with advanced ovarian cancer Top
       
08 Feb 23 Phase III study of Avastin plus chemotherapy in advanced stomach cancer did not meet primary endpoint Top
       
07 Feb 19 US FDA approves Rituxan/MabThera for the most common type of adult leukemia Top
       
06 Feb 11 Roche study drug may offer valuable new treatment option for patients with type 2 diabetes Top
       
05 Feb 03 Strong operating performance for Roche in 2009 Top
       
04 Jan 28 Roche establishes new medical research hub in Singapore Top
       
03 Jan 28 Herceptin now approved in the EU for patients with HER2-positive advanced stomach cancer Top
       
02 Jan 20 Roche invests about 190 Mio Swiss Francs in infusion-free administration device with new Herceptin formulation Top
       
01 Jan 11 FDA approves ACTEMRA for the treatment of moderately to severely active rheumatoid arthritis Top


2009
Sr.No.
Date
News
       
69 Dec17 Roche presents Building 1, its new main office building in Basel Top
       
68 Dec 12 Greater chances of cure for patients with HER2-positive early breast cancer when treated with one year of Herceptin Top
       
67 Dec 11 Avastin plus commonly used chemotherapies improves time without the disease getting worse in women with previously treated advanced breast cancer Top
       
66 Dec 11 Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab in rheumatoid arthritis Top
       
65 Dec 09 Roche Introduces New Automated Clinical Laboratory System for CE-Marked Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae Top
       
64 Dec 09 Important progress in treatment of early and late stage breast cancer with Herceptin, Avastin and T-DM1 Top
       
63 Dec 08 MabThera/Rituxan is the first treatment to show improved overall survival in previously untreated patients with chronic lymphocytic leukemia Top
       
62 Dec 04 MabThera/Rituxan: promising new data in leukemia and lymphatic cancers to be presented at the American Society of Hematology (ASH), the world’s leading meeting in blood cancers Top
       
61 Nov 20 European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancer Top
       
60 Oct 17 ACTEMRA inhibits progression of joint destruction in RA patients by over 80% compared to methotrexate alone Top
       
59 Oct 15 Roche reports further accelerated sales growth in third quarter Top
       
58 Sept 24 Herceptin provides impressive survival benefit for patients with high levels of HER2 in their stomach cancer Top
       
57 Sept 24 Continuous improvements in animal welfare within Roche Research Top
       
56 Sept 23 From inoperable disease to potentially life saving surgery - new Avastin data gives hope to colorectal cancer patients with liver metastases Top
       
55 Sept 23 Roche announces results from two early studies which show promise for patients with malignant melanoma Top
       
54 Sept 22 Avastin could play an important role in improving the daily lives of patients with the most aggressive form of brain cancer Top
       
53 Sept 13 Two new studies report increased survival rates in Tamiflu-treated patients with avian flu (H5N1) and severe seasonal flu Top
       
52 Sept 08 Roche announces new Corporate Executive Committee Top
       
51 Sept 03 Roche recognised as new Super Sector Leader in Dow Jones Sustainability Index Top
       
50 Sept 03 MabThera approved in Europe for use in patients with previously-treated chronic lymphocytic leukaemia Top
       
49 Sept 01 Roche receives CE Mark certification for cobas 8000 modular analyzer series Top
       
48 Aug 18 Avastin plus commonly used chemotherapies improves time without the disease getting worse in women with previously treated advanced breast cancer Top
       
47 Aug 05 Roche Continents takes place for the third time
 Top
       
46 Aug 03 Avastin approved in US for the most common type of kidney cancer
 Top
       
45 July 30 Second Phase III Study Showed Lucentis Improved Vision in Patients with Retinal Vein Occlusion
 Top
       
44 July 29 European commission approves broader label for Avastin allowing combination with docetaxel for the first-line treatment of advanced (metastatic) breast cancer
 Top
       
43 July 24 MabThera receives positive opinion in Europe for treating patients whose chronic lymphocytic leukaemia returns
 Top
       
42 July 23 Double-digit increase in sales, operating profit and Core EPS
 Top
       
41 July 20 Xeloda in combination with oxaliplatin shown to be effective in early colon cancer Top
       
40 July 13 New data from phase III SATURN study shows Tarceva improves overall survival when used immediately after initial chemotherapy in patients with advanced lung cancer Top
       
39 July 02 Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion Top
       
38 July 01 Roche launches novel program to ease Tamiflu access to developing economies Top
       
37 June 11 New data demonstrate the ability of MabThera to reduce the progression of joint damage when used as a first-line biologic treatment in rheumatoid arthritis
 Top
       
36 June 10 New data reinforces long-term efficacy of ACTEMRA in rheumatoid arthritis across all patient population types
 Top
       
35 June 09 Roche to commence phase III trials with innovative treatment designed to lower cardiovascular risk in diabetes patients with recent heart attack
 Top
       
34 June 01 Encouraging first data on new targeted treatment for patients with melanoma - the deadliest form of skin cancer
 Top
       
33 May 31 Herceptin landmark study (ToGA) reveals unprecedented survival benefit in HER2-positive stomach cancer
 Top
       
32 May 30 Maintenance treatment with Avastin and Tarceva in combination helps lung cancer patients live longer without their disease worsening
 Top
       
31 May 30 Full results from first Phase III study of Avastin in adjuvant colon cancer announced
 Top
       
30 May 25 Two-year data reinforce effectiveness of ACTEMRA in inhibiting joint damage and improving physical function in patients with rheumatoid arthritis Top
       
29 May 15 Roche to present major advances with targeted cancer medicines at ASCO
 Top
       
28 May 12 Roche provides additional donation of 5.65 million packs of Tamiflu to World Health Organization
 Top
       
27 May 06 Important New Treatment Option Approved in US for Patients with the Most Aggressive Form of Brain Cancer Top
       
26 May 02 Roche rapidly responds to WHO request to deploy Rapid Response Stockpiles of Tamiflu to tackle global emergence of a new H1N1 influenza A strain - swine flu Top
       
25 Apr 30 Roche responds to WHO move to influenza pandemic alert phase 5 Top
       
24 Apr 29 Roche steps up preparedness level in response to WHO's increase to pandemic alert phase 4 Top
       
23 Apr 22 Phase III C-08 study of Avastin in early-stage colon cancer does not meet primary endpoint Top
       
22 Apr 16 Roche strongly outperforms market in first quarter Top
       
21 Apr 15 Roche Diabetes Care supports "Changing Diabetes in Children"
 Top
       
20 Apr 14 Roche and Genentech announce organizational and leadership decisions Top
       
19 Apr 02 Roche to introduce new LightCycler MRSA Advanced Test in the EU Top
       
18 Mar 26 Roche completes acquisition of Genentech
 Top
       
17 Mar 26 Roche completes tender offer for Genentech

 Top
       
16 Mar 18 Herceptin now shown to significantly prolong the lives of patients with HER2-positive advanced stomach cancer Top
       
15 Mar 16 Roche acquires innovatis AG to complement its product portfolio in the rapidly growing area of cellular analytics
 Top
       
14 Mar 12 Roche and Genentech reach a friendly agreement to combine the two organizations and create a leader in healthcare innovation Top
       
13 Mar 11 Herceptin proven to benefit women with HER2 positive early breast cancer - latest results from the HERA study
 Top
       
12 Mar 10 Roche Annual General Meeting: dividend raised by 9 percent
 Top
       
11 Mar 06 Roche increases offer price for Genentech shares to US$ 93 per share and extends offer Top
       
10 Feb 27 MabThera approved in the EU for patients with chronic lymphocytic leukaemia Top
       
09 Feb 16 For the first time, doctors can predict which hepatitis B patients have the highest chance to achieve treatment success with Pegasys
 Top
       
08 Feb 09 Roche commences tender offer for Genentech for US$86.50 per share in cash
 Top
       
07 Feb 04 Strong operating results for Roche in 2008
 Top
       
06 Feb 03 Avastin and Tarceva in combination significantly improves the time patients with advanced lung cancer can live without their disease worsening
 Top
       
05 Jan 30 Roche intends to commence tender offer to acquire all shares of Genentech for US$ 86.50 per share in cash Top
       
04 Jan 28 Roche delighted about pool extension Top
       
03 Jan 23 Foundation-laying ceremony for new R&D building at Roche Basel Top
       
02 Jan 23 MabThera receives positive opinion in Europe for first-line treatment for chronic lymphocytic leukaemia Top
       
01 Jan 21 RoACTEMRA approved in Europe to treat patients suffering from Rheumatoid Arthritis Top

2008
Sr.No.
Date
News
       
62 Dec 31 FDA approves most comprehensive test for the simultaneous screening of donated blood for HIV, Hepatitis B & Hepatitis C Top
       
61 Dec 19 MabThera inhibits the destruction of joints in patients with early rheumatoid arthritis Top
       
60 Dec 11 Herceptin given prior to surgery improves the chance of survival without relapse for women with HER2-positive breast cancer Top
       
59 Dec 10 New data show that Herceptin, Xeloda and Avastin help patients with early and advanced breast cancer live longer or remain disease free for longer Top
       
58 Dec 8 Jonathan Knowles to retire from Roche at the end of 2009 Top
       
57 Dec 7 New data from largest-ever clinical trials in CLL show MabThera enables leukaemia patients to live longer without their disease progressing Top
       
56 Dec 4 European Commission approval of new indication for Roche's Pegasys offers hepatitis C patients a second chance for a cure Top
       
55 Dec 4 Roche and FDA Agree on Pathway Towards U.S. Approval of Actemra (tocilizumab) Top
       
54 Dec 1 Roche signs definitive agreement to acquire Memory Pharmaceuticals Top
       
53 Nov 25 Roche signs definitive agreement to acquire Memory Pharmaceuticals Top
       
52 Nov 24 Roche to develop alternative project to planned office high-rise Top
       
51 Nov 24 RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid Arthritis Top
       
50 Nov 21 RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid Arthritis Top
       
49 Nov 13 Management Change Corporate Communications
 Top
       
48 Nov 7 Tarceva brings new hope to patients with advanced non-small cell lung cancer Top
       
47 Oct 27 Roche posts sustained double-digit sales growth for the first nine months of 2008
 Top
       
46 Oct 21 Roche posts sustained double-digit sales growth for the first nine months of 2008
 Top
       
45 Oct 17 Roche honors outstanding efforts to develop alternative methods in animal testing
Top
       
44 Oct 7 Pivotal Phase III study shows MabThera delays disease progression in patients with relapsed or refractory Chronic Lymphocytic Leukaemia Top
       
43 Oct 6 Roche announces topline outcomes for Avastin-Tarceva combination study in advanced lung cancer Top
       
42 Oct 3 Genentech, Glycart and Roche enter into collaboration agreement for potential cancer therapy Top
       
41 Oct 1 Roche invests 215 million Swiss francs in diagnostics facility at Penzberg Top
       
40 Sept 30 Roland Wetzel to become new Director of the Tinguely Museum Top
       
39 Sept 18 FDA issues complete response letter to Roche for Actemra Biologics License Application Top
       
38 Sept 16 New data confirms Avastin as the only biologic to demonstrate overall survival when used first-line in metastatic colorectal cancer patients with K-RAS (wild-type) gene status Top
       
37 Sept 10 Roche to present data showing progress in treating lung, gastric and brain cancers at ESMO Top
       
36 Sept 8 Changes in Corporate Communications Top
       
35 Aug 29 Toshio Hosokawa is fifth Roche Commissions composer Top
       
34 Aug 15 Roche and the Chocos Village Project in Peru: making a lasting difference to people`s lives Top
       
33 Aug 15 Roche and Meda agree on product transactions Top
       
32 Aug 13 Roche Continents: creativity and innovation in Arts and Science  Top
       
31 Jul 30 FDA Advisory Committee recommends approval of Actemra for the treatment of rheumatoid arthritis Top
       
30 Jul 24 Statement - Roche has not incorporated "a molecule" into Mircera Top
       
29 Jul 23 Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics Top
       
28 Jul 22 Roche acquires Mirus to advance research in the field of RNAi delivery Top
       
27 Jul 21 Roche posts very good results: strong market outperformance - guidance confirmed Top
       
26 Jul 21 Roche makes offer to acquire all outstanding shares of Genentech for US $89.00 per share in cash Top
       
25 Jun 26 European approval for Roche`s Pegasys personalises treatment for a subgroup of hepatitis C patients: chance for cure with only four months of treatment Top
       
24 Jun 24 Roche`s tender offer to increase ownership stake in Chugai successful Top
       
23 Jun 20 Roche sets up international Postdoc Fellowship programme  Top
       
22 Jun 13 New data reveals Actemra is the first and only biologic drug to show superiority over current standard of care in rheumatoid arthritis Top
       
21 Jun 10 Roche moves investigational diabetes drug, Taspoglutide, into Phase III clinical trials Top
       
20 May 31 Study confirms that Avastin significantly increases chance of living without disease progression in metastatic breast cancer Top
       
19 May 30 Continuing Herceptin treatment prevents disease progression in women with aggressive metastatic breast cancer Top
       
18 May 22 Roche to increase its stake in Chugai from 50.1% to 59.9% Top
       
17 May 9 Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis Top
       
16 April 17 Roche continues solid sales growth in first quarter of 2008 - both divisions significantly outpace their markets Top
       
15 April 16 Actemra approved in Japan to treat patients with rheumatoid arthritis Top
       
14 April 15 Roche fully acquires privately-owned biotech company Piramed Top
       
13 Mar 04 Roche raises dividend by 35 percent Top
       
12 Feb 23 FDA grants accelerated approval of Avastin in combination with paclitaxel chemotherapy for first-line treatment of patients with advanced HER2-negative breast cancer  Top
       
11 Feb 19 Roche Completes Tender Offer for Ventana Shares Top
       
10 Feb 13 Second phase III study of Avastin in 1st line metastatic breast cancer meets its primary endpoint Top
       
09 Feb 08 Roche purchases shares in tender offer for Ventana Top
       
08 Jan 30 Annual Media Conference Top
       
07 Jan 30 Record operating results for Roche again in 2007 Top
       
06 Jan 28 Avastin receives broad label extension in Europe for the treatment of patients with metastatic colorectal cancer  Top
       
05 Jan 25 MabThera meets study primary endpoint in improving disease symptoms when used as first biologic therapy in patients with rheumatoid arthritis Top
       
04 Jan 25 MabThera increases the time patients with the most common form of adult leukaemia live without their cancer progressing  Top
       
03 Jan 22 Roche to Acquire Ventana for $89.50 per share Top
       
02 Jan 18 Roche invests 430 million Swiss francs at sites in Germany and Switzerland Top
       
01 Jan 09 Roche engages in four additional AIDS Technology Transfers to strengthen local manufacturing in world´s poorest countries Top


2007
Sr.No.
Date
News
       
67 Dec 19 Avastin approved in Europe for first-line treatment of patients with advanced kidney cancer Top
       
66 Dec 13 Roche launches Employee Secondment Policy  Top
       
65 Dec 11 Changes to the Corporate Executive Committee Top
       
64 Dec 06 Roche to nominate independent directors for election at Ventana`s 2008 annual stockholders meeting Top
       
63 Nov 21 Roche Submits Application for FDA Approval of Actemra for the Treatment of Rheumatoid Arthritis Top
       
62 Nov 16 Avastin receives positive opinion in Europe for first-line treatment of patients with advanced kidney cancer Top
       
61 Nov 15 FDA approves Mircera: first renal anemia treatment in the US with monthly maintenance dosing Top
       
60 Nov 14 Roche Confirms Commencement of Due Diligence with Ventana Top
       
59 Nov 13 Roche signs licensing and settlement agreements for Hepatitis C immunodiagnostics Top
       
58 Nov 02 Treatment with Pegasys provides hepatitis C patients a second chance to achieve a cure after not responding to Peg-Intron Top
       
57 Oct 23 Roche Considering Legal Options In Patent Litigation Case Top
       
56 Oct 22 Tarceva approved for lung cancer in Japan
 Top
       
55 Oct 19 European licence for Roche HIV drug Viracept re-established by European Commission Top
       
54 Oct 19 Pivotal Mircera study first to convert dialysis patients from frequent dosing directly to once every four weeks Top
       
53 Oct 16 Japanese Red Cross selects Roche as partner for nucleic acid screening of entire Japanese blood supply Top
       
52 Oct 16 Strong sales growth in the first nine months of 2007 - full-year outlook and Core Earnings per Share target reaffirmed Top
       
51 Oct 02 Jürgen Schwiezer named new CEO Division Roche Diagnostics - Succession to take effect as of January 1, 2008  Top
       
50
Sept 28
 Roche confirms site development plans: go-ahead for office high-rise Top
       
49
Sept 26
 Herceptin eradicates tumours and may reduce the need for mastectomies in women with inflammatory HER2-positive breast cancer - one of the most aggressive and fastest growing forms of the disease Top
       
48
Sept 20
 European licence for Roche HIV drug Viracept recommended for re-instatement Top
       
47
Sept 20
 Roche wins first Financial Times / Citi Private Bank Environmental Award and was reselected for inclusion in the Dow Jones Sustainability Indexes Top
       
46
Sept 20
 New child sized Tamiflu capsules receive European approval  Top
       
45
Aug 24
Avastin approved in Europe for first-line treatment of patients with advanced lung cancer Top
       
44
Aug 21
Roche extends tender offer for Ventana Top
       
43
Aug 13
Roche and Actavis agree on product transactions
 Top
 
42
Jul 26
Top
 
41
Jul 26
Top
 
40
Jul 25
Top
 
39
Jul 25
Top
 
38
Jul 23
Top
 
37
Jul 20
Top
 
36
Jul 19
Top
 
35
Jul 19
Top
 
34
Jul 11
Top
   
33
Jul 09
Roche and Alnylam form major alliance on RNAi therapeutics Top
       
32
Jun 27
Preliminary results for phase III study evaluating CellCept in lupus nephritis Top
       
31
Jun 25
Roche makes offer to acquire Ventana for 75 US dollars per share in cash Top
       
30
Jun 25
Roche and Toyama Chemical enter licensing agreement to develop potential breakthrough drug to treat rheumatoid arthritis
 Top
       
29
Jun 25
Once monthly Mircera could save about 50% of the time health professionals spend on anaemia management in dialysis centres each year Top
       
28
Jun 21
Roche establishes Viracept Patient Registries in the interest of patient care Top
       
27
Jun 19
Roche acquires NimbleGen to gain entry into high-growth research microarrray market  Top
       
26
Jun 15
Actemra: Roche´s novel rheumatoid arthritis drug shows substantial benefits for patients in OPTION study Top
 
   
25
Jun 06
Roche recalls Viracept due to chemical impurity Top
   
24
Jun 06
Actemra: New data confirms significant improvement of disease signs and symptoms in patients with rheumatoid arthritis Top
   
23
Jun 04
Investigational cancer drug Pertuzumab shows promising results in advanced breast cancer when combined with Herceptin Top
   
22
May 25
       
22
May 21
Roche receives approvable letter for Mircera in the United States Top
       
21
May 14
Highly sensitive and accurate Roche HIV-1 Test approved by FDA Top
   
20
May 03
 Herceptin approved in Europe for use in combination with an aromatase inhibitor for the treatment of patients with HER2 and hormone receptor-co-positive metastatic breast cancer Top
   
19
Apr 26
 Roche update on Tamiflu for pandemic influenza preparedness Top
   
18
Apr 18
 Breakthrough cancer drug Avastin approved in Japan for use in advanced or recurrent colorectal cancer Top
   
17
Apr 18
 Roche posts strong first quarter sales - upgrade of Core Earnings per Share outlook for 2007 Top
   
16
Apr 11
Roche and Transgene enter partnership on therapeutic vaccines against HPV-mediated diseases Top
     
15
Apr 04
 Roche to acquire BioVeris to expand its leading ECL immunochemistry business into new market segments Top
   
14
Apr 02
Roche acquires THP to expand its therapeutic antibody research Top
   
13
Mar 30
Xeloda approved in Europe for the treatment of advanced stomach cancer Top
   
12
Mar 29
Avastin approved in Europe for first line treatment of women with metastatic breast cancer Top
   
11
Mar 05
 Roche raises dividend by 36 percent Top
       
10
Feb 26
 Positive recommendation for Avastin use in advanced or recurrent colorectal cancer in Japan
 Top
     
09
Feb 23
Recruitment temporarily suspended into C.E.R.A. Phase II oncology trial Top
       
08
Feb 23
Oral cancer drug Xeloda receives positive opinion from the European Authorities for the treatment of advanced gastric cancer
 Top
   
07
Feb16
 Roche files application in Europe for Tamiflu 30 and 45 mg capsules Top
   
06
Feb 07
 Annual Media Conference Top
   
05
Feb 07
 Roche posts outstanding results for 2006 Top
   
04
 Jan 29 Tarceva : European approval for pancreatic cancer treatment Top
     
03
 Jan 26 Copegus approved in Japan as combination therapy with Pegasys for patients with chronic hepatitis C Top
     
02
 Jan 24 First Actemra multinational phase III trial demonstrates significant improvement in signs and symptoms of rheumatoid arthritis Top
       
01
 Jan 10 NeoRecormon gains European approval for convenient once weekly treatment of anaemia in patients with solid cancers Top

2006
Sr.No.
Date
News
       
59
 Dec 15 Tarceva receives positive EU opinion for the treatment of metastatic pancreatic cancer Top
     
58
 Dec 15 Roche offers the FDA additional Mircera data Top
     
57
 Dec 13 Changes to the Roche Board of Directors and executive management Top
       
56
Dec 6
 
   
55
Dec 5
 New nanomechanical method for detecting disease- and treatment-relevant genes Top
 
   
54
Dec 4
Employees support children affected by HIV/AIDS at the Annual Roche AIDS Walk Top
     
53
 Nov 20 Mircera - first drug to correct anaemia in all chronic kidney disease patients with a simple twice-monthly dosing schedule Top
     
52
 Nov 16 The Salzburg Festival and Roche launch the "Continents..." cultural project Top
     
51
 Nov 16 Statement - Label changes for Tamiflu Top
     
50
 Oct 20 Science Magazine ranks Roche No. 3 among Top Employers in the Biotech and Pharmaceutical Industries Top
     
49
 Oct 17 Roche´s nine-month sales hit record high Top
     
48
 Oct 17 Roche and InterMune sign agreement to collaborate on the research, development and commercialization of Hepatitis C Protease Inhibitors Top
     
47
 Oct 02 Additional benefit for patients resulting from combination therapies with Roche cancer medicines Top
     
46
 Oct 02 Tamiflu readily available for 2006/2007 influenza season Top
     
45
 Sept 22 First Technology Transfers from Roche to enable local production of HIV medicine for Africa Top
       
44
 Sept 14 Roche development plans: a clear commitment to the Basel site Top
       
43
 Sept 01 International Trade Commission rules in Roche´s favour - Mircera case terminated
Top
     
42
 Sept 01 George Benjamin is fourth Roche Commissions composer Top
       
41
 Aug 08 Avastin filed in Europe for treatment of most common form of lung cancer
 Top
       
40
 July 31 Avastin and Xeloda meet primary endpoints in large Phase III first line metastatic colorectal cancer study
 Top
       
39
 July 28 In the interests of patients, Roche will consider all options following CHMP opinion on Tarceva in pancreatic cancer
 Top
     
38
 July 10 Avastin filed in Europe for first-line treatment of women with advanced breast cancer Top
     
37
 June 27 US Phase III study of Avastin in advanced pancreatic cancer does not meet primary endpoint Top
     
36
 June 22 New evidence shows MabThera inhibits joint damage in patients with rheumatoid arthritis Top
     
35
 June 03 New data show impressive survival benefit for Herceptin in early-stage HER2-positive breast cancer Top
     
34
 June 02 MabThera recommended for approval in rheumatoid arthritis in Europe Top
     
33
 May 29 Herceptin added to hormonal therapy prolongs progression-free survival for patients with advanced HER2-positive breast cancer Top
     
32
 May 26 Avastin filed with FDA in US for treatment of women with advanced breast cancer
 Top
     
31
 May 24 Herceptin approved in Europe for early use in HER2-positive breast cancer Top
     
30
 May 23 Recruitment to resume in AVANT international phase III trial in post-surgical adjuvant colon cancer Top
     
29
 May 19 Transparency in clinical trials: more than 300 protocol and study results published on www.roche-trials.com since April 2005 Top
     
28
 May 16 Roche reaches agreement with Aspen to provide influenza medicine for Africa Top
     
27
 May 10 Statement - Tamiflu - alternative syntheses Top
     
26
 May 08 New Genetic Research Method Sheds Light on Drug Metabolism Top
     
25
 May 03 Cambodia Treatment Programme enrols over 1000 HIV/AIDS patients Top
     
24
 Apr 28 Chugai submitted Actemra in rheumatoid arthritis and a severe form of juvenile arthritis for approval in Japan Top
     
23
 Apr 28 Herceptin receives positive opinion in Europe for early use in HER2-positive breast cancer Top
     
22
 Apr 26 Roche showed continued strong sales growth in the first quarter 2006 – sales up by 15% Top
     
21
 Apr 21 Chugai files innovative cancer medicine Avastin for fast approval in Japan Top
     
20
 Apr 19 Rapid response stockpile of Tamiflu now ready and available to the World Health Organisation (WHO) Top
     
19
 Apr 12 Avastin filed in US for treatment of most common form of lung cancer Top
     
18
 Apr 06 Oral chemotherapy Xeloda shown to be effective in stomach cancer Top
     
17
 Mar 31 New Bonviva Quarterly Injection Approved in Europe for Postmenopausal Osteoporosis Top
     
16
 Mar 16 Roche update on Tamiflu for pandemic influenza preparedness Top
     
15
 Mar 01 FDA Approves First Rheumatoid Arthritis Indication for Rituxan (MabThera)
 Top
     
14
 Feb 27 Roche raises dividend by 25 percent Top
     
13
 Feb 17 Roche files Herceptin for early-stage HER2-positive breast cancer with European Authorities Top
     
12
 Feb 13 Recruitment temporarily suspended in an international phase III trial (AVANT) in post-surgical adjuvant colon cancer Top
     
11
 Feb 01 Annual Media Conference Top
     
10
 Feb 01 Roche 2005: Record sales and operating profit Top
     
09
 Jan 31 Tamiflu gains approval in Europe for prevention of influenza in children aged 1 to 12 years Top
     
08
 Jan 27 European positive opinion for first quarterly I.V. injection for postmenopausal osteoporosis Top
     
07
 Jan 24 US FDA joint advisory committee recommends approval of weight loss drug Orlistat 60mg capsules for over the counter use Top
     
06
 Jan 19 Statement – In response to paper by Jefferson et al., published in the Lancet, 19 January 2006, “Antivirals for influenza in healthy adults: systematic review” Top
     
05
 Jan 17 Roche donates a further 2 million treatment courses of antiviral Tamiflu to the WHO for regional stockpiling Top
     
04
 Jan 12 Roche offers help to local manufacturers to produce HIV medicine for sub-Saharan Africa and Least Developed Countries Top
     
03
 Jan 12 Roche’s rapid sepsis test now available in the European Union Top
     
02
 Jan 09 FDA approves first quarterly I.V. injection for postmenopausal osteoporosis in US Top
     
01
 Jan 09 Roche and Amira Pharmaceuticals announce innovative alliance model Top